US Stock MarketDetailed Quotes

TFFP TFF Pharmaceuticals

Watchlist

1.7800
+0.1200+7.23%

Close Jul 1 16:00 ET

1.7800
0.00000.00%

Post 19:49 ET

5.51MMarket Cap-189P/E (TTM)

TFF Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

27.98%-3.14M

41.34%-16.04M

45.29%-4.21M

59.34%-3M

11.09%-4.46M

39.75%-4.37M

7.49%-27.34M

29.23%-7.7M

-2.61%-7.38M

14.87%-5.01M

Net income from continuing operations

18.67%-5.74M

33.13%-21.24M

35.41%-4.76M

39.39%-4.41M

42.60%-5.02M

15.81%-7.05M

-2.36%-31.77M

26.63%-7.37M

16.18%-7.27M

-87.86%-8.75M

Depreciation and amortization

13.82%140.18K

29.43%502.48K

8.07%130.67K

23.71%125.12K

38.57%123.53K

59.90%123.17K

248.33%388.22K

56.97%120.91K

255.54%101.14K

1,887.65%89.15K

Other non cash items

-1.88%-27.22K

---497.03K

---529K

--49K

--9.69K

---26.72K

----

Change In working capital

69.81%1.85M

819.27%1.53M

126.56%364.71K

140.30%468.13K

-116.21%-396.86K

971.76%1.09M

90.26%-212.15K

25.02%-1.37M

-293.04%-1.16M

223.63%2.45M

-Change in receivables

615.71%128.44K

-145.81%-259.8K

-105.62%-48.01K

-257.35%-89.52K

-1,386.00%-97.36K

90.27%-24.91K

121.59%567.13K

236.34%854.71K

95.46%-25.05K

99.55%-6.55K

-Change in prepaid assets

-56.47%298.31K

715.36%1.48M

105.14%64.43K

31.29%648.56K

-88.27%82.42K

188.38%685.33K

189.30%181.6K

22.27%-1.25M

-56.00%493.97K

381.48%702.35K

-Change in payables and accrued expense

232.75%1.41M

140.97%405.48K

129.74%338.57K

98.74%-21.6K

-120.05%-333.82K

119.72%422.33K

-573.05%-989.59K

-1,789.51%-1.14M

-3,148.50%-1.71M

640.97%1.66M

-Change in other current liabilities

-13.02%-20.1K

-59.54%-75.47K

-13.01%-19.7K

-13.02%-19.31K

-46.05%-18.67K

---17.78K

---47.3K

---17.43K

---17.09K

---12.78K

-Change in other working capital

56.00%39K

-132.89%-25K

-83.67%29.43K

-152.79%-50K

-129.43%-29.43K

108.36%25K

-82.83%76K

-61.41%180.2K

478.84%94.71K

300.00%100K

Cash from discontinued investing activities

Operating cash flow

27.98%-3.14M

41.34%-16.04M

45.29%-4.21M

59.34%-3M

11.09%-4.46M

39.75%-4.37M

7.49%-27.34M

29.23%-7.7M

-2.61%-7.38M

14.87%-5.01M

Investing cash flow

Cash flow from continuing investing activities

93.89%-94.75K

67.14%-46.39K

98.37%-12.65K

-78.62%-1.55M

-11.46%-141.17K

-448.90%-777.48K

-299.29%-495.45K

Net PPE purchase and sale

----

93.89%-94.75K

67.14%-46.39K

98.37%-12.65K

----

-78.62%-1.55M

-11.46%-141.17K

-448.90%-777.48K

-299.29%-495.45K

Cash from discontinued investing activities

Investing cash flow

----

93.89%-94.75K

67.14%-46.39K

98.37%-12.65K

----

-78.62%-1.55M

-11.46%-141.17K

-448.90%-777.48K

-299.29%-495.45K

Financing cash flow

Cash flow from continuing financing activities

5,128.68%901.14K

-57.34%5.01M

-99.99%567

1,081.70%5.09M

-270.30%-59.23K

-17.92K

-59.32%11.75M

11.34M

430.74K

-161.63%-16K

Net common stock issuance

--12.58K

-56.00%5.12M

-99.71%32.12K

----

--0

-58.45%11.64M

--11.24M

----

Proceeds from stock option exercised by employees

--903.56K

--0

-87.26%110.82K

--100.64K

--0

----

Net other financing activities

16.29%-15K

---108.7K

---31.55K

--0

---59.23K

---17.92K

----

Cash from discontinued financing activities

Financing cash flow

5,128.68%901.14K

-57.34%5.01M

-99.99%567

1,081.70%5.09M

-270.30%-59.23K

---17.92K

-59.32%11.75M

--11.34M

--430.74K

-161.63%-16K

Net cash flow

Beginning cash position

-67.02%5.48M

-50.84%16.61M

-26.02%9.73M

-63.32%7.66M

-53.75%12.22M

-50.84%16.61M

-4.27%33.79M

-70.60%13.15M

-59.88%20.89M

-54.50%26.41M

Current changes in cash

48.83%-2.24M

35.13%-11.12M

-221.94%-4.26M

126.88%2.08M

17.60%-4.55M

40.63%-4.38M

-1,012.79%-17.14M

131.73%3.49M

-5.36%-7.73M

7.73%-5.53M

Effect of exchange rate changes

-88.17%-23.06K

63.21%-14.67K

142.24%11.79K

18.20%-13.88K

-116.30%-322

-504.26%-12.25K

-216.05%-39.87K

-131.38%-27.91K

6.30%-16.97K

130.46%1.98K

End cash Position

-73.71%3.21M

-67.02%5.48M

-26.02%9.73M

-63.32%7.66M

-53.75%12.22M

-50.84%16.61M

-70.60%13.15M

-59.88%20.89M

Free cash flow

27.98%-3.14M

44.16%-16.13M

45.68%-4.26M

63.06%-3.01M

18.44%-4.49M

40.87%-4.37M

5.04%-28.89M

28.76%-7.84M

-11.23%-8.16M

8.39%-5.51M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	27.98%-3.14M	41.34%-16.04M	45.29%-4.21M	59.34%-3M	11.09%-4.46M	39.75%-4.37M	7.49%-27.34M	29.23%-7.7M	-2.61%-7.38M	14.87%-5.01M
Net income from continuing operations	18.67%-5.74M	33.13%-21.24M	35.41%-4.76M	39.39%-4.41M	42.60%-5.02M	15.81%-7.05M	-2.36%-31.77M	26.63%-7.37M	16.18%-7.27M	-87.86%-8.75M
Depreciation and amortization	13.82%140.18K	29.43%502.48K	8.07%130.67K	23.71%125.12K	38.57%123.53K	59.90%123.17K	248.33%388.22K	56.97%120.91K	255.54%101.14K	1,887.65%89.15K
Other non cash items	-1.88%-27.22K	---497.03K	---529K	--49K	--9.69K	---26.72K	----	----	----	----
Change In working capital	69.81%1.85M	819.27%1.53M	126.56%364.71K	140.30%468.13K	-116.21%-396.86K	971.76%1.09M	90.26%-212.15K	25.02%-1.37M	-293.04%-1.16M	223.63%2.45M
-Change in receivables	615.71%128.44K	-145.81%-259.8K	-105.62%-48.01K	-257.35%-89.52K	-1,386.00%-97.36K	90.27%-24.91K	121.59%567.13K	236.34%854.71K	95.46%-25.05K	99.55%-6.55K
-Change in prepaid assets	-56.47%298.31K	715.36%1.48M	105.14%64.43K	31.29%648.56K	-88.27%82.42K	188.38%685.33K	189.30%181.6K	22.27%-1.25M	-56.00%493.97K	381.48%702.35K
-Change in payables and accrued expense	232.75%1.41M	140.97%405.48K	129.74%338.57K	98.74%-21.6K	-120.05%-333.82K	119.72%422.33K	-573.05%-989.59K	-1,789.51%-1.14M	-3,148.50%-1.71M	640.97%1.66M
-Change in other current liabilities	-13.02%-20.1K	-59.54%-75.47K	-13.01%-19.7K	-13.02%-19.31K	-46.05%-18.67K	---17.78K	---47.3K	---17.43K	---17.09K	---12.78K
-Change in other working capital	56.00%39K	-132.89%-25K	-83.67%29.43K	-152.79%-50K	-129.43%-29.43K	108.36%25K	-82.83%76K	-61.41%180.2K	478.84%94.71K	300.00%100K
Cash from discontinued investing activities
Operating cash flow	27.98%-3.14M	41.34%-16.04M	45.29%-4.21M	59.34%-3M	11.09%-4.46M	39.75%-4.37M	7.49%-27.34M	29.23%-7.7M	-2.61%-7.38M	14.87%-5.01M
Investing cash flow
Cash flow from continuing investing activities		93.89%-94.75K	67.14%-46.39K	98.37%-12.65K			-78.62%-1.55M	-11.46%-141.17K	-448.90%-777.48K	-299.29%-495.45K
Net PPE purchase and sale	----	93.89%-94.75K	67.14%-46.39K	98.37%-12.65K	----	----	-78.62%-1.55M	-11.46%-141.17K	-448.90%-777.48K	-299.29%-495.45K
Cash from discontinued investing activities
Investing cash flow	----	93.89%-94.75K	67.14%-46.39K	98.37%-12.65K	----	----	-78.62%-1.55M	-11.46%-141.17K	-448.90%-777.48K	-299.29%-495.45K
Financing cash flow
Cash flow from continuing financing activities	5,128.68%901.14K	-57.34%5.01M	-99.99%567	1,081.70%5.09M	-270.30%-59.23K	-17.92K	-59.32%11.75M	11.34M	430.74K	-161.63%-16K
Net common stock issuance	--12.58K	-56.00%5.12M	-99.71%32.12K	----	----	--0	-58.45%11.64M	--11.24M	----	----
Proceeds from stock option exercised by employees	--903.56K	--0	--0	--0	--0	--0	-87.26%110.82K	--100.64K	--0	----
Net other financing activities	16.29%-15K	---108.7K	---31.55K	--0	---59.23K	---17.92K	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	5,128.68%901.14K	-57.34%5.01M	-99.99%567	1,081.70%5.09M	-270.30%-59.23K	---17.92K	-59.32%11.75M	--11.34M	--430.74K	-161.63%-16K
Net cash flow
Beginning cash position	-67.02%5.48M	-50.84%16.61M	-26.02%9.73M	-63.32%7.66M	-53.75%12.22M	-50.84%16.61M	-4.27%33.79M	-70.60%13.15M	-59.88%20.89M	-54.50%26.41M
Current changes in cash	48.83%-2.24M	35.13%-11.12M	-221.94%-4.26M	126.88%2.08M	17.60%-4.55M	40.63%-4.38M	-1,012.79%-17.14M	131.73%3.49M	-5.36%-7.73M	7.73%-5.53M
Effect of exchange rate changes	-88.17%-23.06K	63.21%-14.67K	142.24%11.79K	18.20%-13.88K	-116.30%-322	-504.26%-12.25K	-216.05%-39.87K	-131.38%-27.91K	6.30%-16.97K	130.46%1.98K
End cash Position	-73.71%3.21M	-67.02%5.48M	-67.02%5.48M	-26.02%9.73M	-63.32%7.66M	-53.75%12.22M	-50.84%16.61M	-50.84%16.61M	-70.60%13.15M	-59.88%20.89M
Free cash flow	27.98%-3.14M	44.16%-16.13M	45.68%-4.26M	63.06%-3.01M	18.44%-4.49M	40.87%-4.37M	5.04%-28.89M	28.76%-7.84M	-11.23%-8.16M	8.39%-5.51M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall